Videoimaging of prostatic stromal-cell contraction: An in vitro model for studying drug effects

Prostate

Volumn 37, Issue 4, 1998, Pages 209-214

  Corvin, Stefan ^a   Bösch, Simone T ^a   Eder, Iris ^a   Thurnher, Martin ^a   Bartsch, Georg ^a   Klocker, Helmut ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Contraction; Doxazosin; Phenylephrine; Prostatic stromal cells; Video microscopy

Indexed keywords

DOXAZOSIN; PHENYLEPHRINE;

ADRENERGIC STIMULATION; ARTICLE; BLADDER NECK STENOSIS; CELL STRUCTURE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY; PRIORITY JOURNAL; PROSTATE; PROSTATE HYPERTROPHY; QUANTITATIVE DIAGNOSIS; STROMA CELL; VIDEORECORDING;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXAZOSIN; HUMANS; MALE; MICROSCOPY, VIDEO; PHENYLEPHRINE; PROSTATE; STROMAL CELLS;

EID: 0031759413     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19981201)37:4<209::AID-PROS1>3.0.CO;2-U     Document Type: Article

References (22)

1. Bartsch G, Müller HR, Oberholzer M, Rohr HP: Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. J Urol 1979;122:487-491.
2. Bartsch G, Brungger A, Schweikert U, Hintner H, Hopfl R, Rohr HP: Benign prostatic hyperplasia: A stromal disease. Urologe [A] 1989;28:321-328.
3. Shapiro E, Hartanto V, Lepor H: Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis. J Urol 1992;147:1167-1170.
4. 1C-) adrenoceptor subtype. Br J Pharmacol 1995;115:781-786.
5. 1-adrenoceptors in human prostate: Implications for adrenoceptor classification. Mol Pharmacol 1996;49:209-215.
6. 1-adrenoceptor antagonists in benign prostatic hyperplasia: Rationale and clinical experience. Eur Urol 1996;29:129-144.
7. 1-adrenoceptor antagonists. Urologe [A] 1997;36:18-34.
8. Zhang J, Hess M, Thurnher M, Hobisch A, Radmayr C, Cronauer MV, Hitmair A, Culig Z, Bartsch G, Klocker H: Human prostatic smooth muscle cells in culture: Estradiol enhances expression of smooth muscle cell-specific markers. Prostate 1997; 30:117-129.
9. Kooistra A, Elissen NMJ, König JJ, Vermey M, van der Kwast TH, Romijn JC, Schröder FH: Immunocytochemical characterization of explant cultures of human prostatic stromal cells. Prostate 1995;27:42-49.
10. Kassen A, Sutkowski DM, Ahn H, Sensibar JA, Kozlowski JM, Lee C: Stromal cells of the human prostate: Initial isolation and characterization. Prostate 1996;28:89-97.
11. Story MT, Hopp KA, Meier DA: Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells. Prostate 1996;28:219-226.
12. Yazawa H, Saita Y, Iida E, Honma Y, Morita T, Honda K: Characterization of muscarinic cholinoceptor in primary culture of smooth muscle cells from human prostate. J Urol 1994;152:2173-2177.
13. Wu YX, Kawabe K: Primary culture of smooth muscle cells from benign prostatic hyperplasia. J Smooth Muscle Res 1994;30:51-56.
14. Sappino AP, Schürch W, Gabbiani A: Biology of disease: Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990;63:144-161.
15. Schmitt-Graeff A, Gabbiani G: Phenotypic features of stromal cells in normal, premalignant and malignant conditions. Eur J Cancer 1992;28:1916-1920.
16. Lepor H, Shapiro E, Bowsher RR, Henry DP: Determination of norepinephrine levels in the adult human prostate. J Urol 1990; 144:1263-1266.
17. Ishigooka M, Hashimoto T, Hayami S, Suzuki Y, Sasagawa I, Nakada T: Correlation between morphometric differences and norepinephrine content in benign prostatic hyperplasia. Prostate 1996;28:385-391.
18. Lepor H, Tang R, Shapiro E: The alpha-adrenoceptor subtype, mediating the tension of human prostatic smooth muscle. Prostate 1993;22:301-307.
19. Gillenwater JY, Conn RL, Chrysant SG, Roy J, Gaffney M, Ice K, Dias N: Doxazosin for the treatment of benign prostatic hyperplasia in patients with mild to moderate essential hypertension: A double blind, placebo-controlled, dose-response multicenter study. J Urol 1995;154:110-115.
20. Stokes GS, Johnston HJ, Okoro EO, Boutagy J, Monaghan JC, Marwood JF: Comparative and combined efficacy of doxazosin and enalapril in hypertensive patients. Clin Exp Hypertens [A] 1994;16:709-727.
21. Lepor H, Baumann M, Shapiro E: Binding and functional properties of doxazosin in the human prostate adenoma and canine brain. Prostate 1990;16:29-38.
22. Litvak JP, Borkowski A, Jacobs SC, Kyprianou N: Induction of prostate apoptosis by doxazosin: Targeting alpha 1 blockade in benign prostatic hyperplasia. J Urol 1997;157:279.